<DOC>
	<DOCNO>NCT00103662</DOCNO>
	<brief_summary>The purpose study determine whether combination AMD3100 ( plerixafor ) granulocyte colony-stimulating factor ( G-CSF , generic name filgrastim ) good G-CSF alone mobilize collect optimal number stem cell multiple myeloma patient autologous transplantation .</brief_summary>
	<brief_title>Mobilization Stem Cells With AMD3100 ( Plerixafor ) Multiple Myeloma Patients</brief_title>
	<detailed_description>A peripheral stem cell transplant may able replace blood-forming cell destroy chemotherapy . Currently filgrastim ( G-CSF ) , colony stimulate factor , use cause growth mobilization stem cell bone marrow peripheral blood , collect peripheral blood process call apheresis . Plerixafor aids release stem cell bone marrow peripheral blood , possibly allow rapid collection large number stem cell peripheral blood . Larger stem cell dose transplantation correlate faster recovery times high dose chemotherapy follow stem cell transplantation . This study intend determine whether combination plerixafor filgrastim ( G-CSF ) good filgrastim ( G-CSF ) alone help multiple myeloma patient collect least 6 million stem cell two less apheresis session . This study previously post AnorMED , Inc . In November 2006 , AnorMED , Inc. acquire Genzyme Corporation . Genzyme Corporation sponsor trial .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>JM 3100</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Diagnosis multiple myeloma first second complete partial remission &gt; = 4 week since last cycle chemotherapy ( thalidomide , dexamethasone , Velcade consider prior chemotherapy purpose study ) Recovered acute toxic effect prior chemotherapy Eastern Cooperative Oncology Group ( ECOG ) performance status 0 1 White Blood Cell count ( WBC ) &gt; 2.5*10^9/L Absolute polymorphonuclear leukocyte ( PMN ) count &gt; 1.5*10^9/L Platelet ( PLT ) &gt; 100*10^9/L Serum creatinine &lt; =2.2 mg/dL Cardiac pulmonary status sufficient undergo apheresis transplantation Negative HIV Exclusion Criteria ) : Failed previous stem cell collection Previous stem cell transplantation Brain metastases myelomatous meningitis Radiation â‰¥ 50 % pelvis Abnormal electrocardiogram ( ECG ) rhythm disturbance ( ventricular arrhythmia ) conduction abnormality Received boneseeking radionuclides ( e.g . holmium ) A residual acute medical condition result prior chemotherapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>78 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>